Safety and Efficacy of Anti-Programmed Cell Death-1 Monoclonal Antibodies Before and after Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: a Multicenter Retrospective Study. Ito Ayumu , Kim Sung-Won , Matsuoka Ken-ichi , Kawakita Toshiro , Tanaka Takashi , Inamoto Yoshihiro , Toubai Tomomi , Fujiwara Shin-ichiro , Fukaya Masafumi , Kondo Tadakazu , Sugita Junichi , Nara Miho , Katsuoka Yuna , Imai Yosuke , Nakazawa Hideyuki , Kawashima Ichiro , Sakai Rika , Ishii Arata , Onizuka Makoto , Takemura Tomonari , Terakura Seitaro , Iida Hiroatsu , Nakamae Mika , Higuchi Kohei , Tamura Shinobu , Yoshioka Satoshi , Togitani Kazuto , Kawano Noriaki , Suzuki Ritsuro , Suzumiya Junji , Izutsu Koji , Teshima Takanori , Fukuda Takahiro International journal of hematology（2020）
关键词
Anti-PD-1 monoclonal antibody, Immune checkpoint inhibitor, Hodgkin lymphoma, Allogeneic hematopoietic cell transplantation
AI 理解论文
溯源树
样例
